Biosimilars Regulation, Law & Policy: At a Crossroads?

 

 

 

CANCELLED

 

 

 

 

 

 

 

your Co-Chairs

Brian Malkin Esq., Counsel, Arent Fox

George O’Brien Esq., Senior Associate, Hogan Lovells

your Keynote Speaker

Christine Simmon Esq., Senior VP-Policy, Association for Accessible Medicines (AAM, formerly GPhA), and Executive Director of AAM’s Biosimilars Council

WHO WILL BENEFIT

• Executive suite
• Strategic planners
• Regulatory affairs
• QA/QR/QC
• Manufacturing executives
• R&D
• Marketing/sales
• Legal counsel

TEAM DISCOUNTS

Significant tuition discounts are available for teams of two or more from the same company. You must register at the same time and provide a single payment to take advantage of the discount.

• 2-4 attendees 10%
• 5-6 attendees 15%
• 7-9 attendees 20%
• 10+ attendees 25%